An Independent Tribunal appointed under Article 8.1 of the 2017 Tennis Anti-Doping Program (the "Program") has found that Sara Errani committed an Anti-Doping Rule Violation under Article 2.1 of the Program and, as a consequence, has disqualified the affected results and imposed a period of ineligibility of two months, commencing on 3 August 2017.
Ms. Errani, a 29-year-old player from Italy, provided a urine sample on 16 February 2017 as part of an Out-of-Competition test under the Program. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain letrozole, which is an aromatase inhibitor that is included under section S4 (Hormone and Metabolic Modulators) of the 2017 WADA Prohibited List, and therefore is also prohibited under the Program.
On 18 April 2017, Ms. Errani was charged with an Anti-Doping Rule Violation under Article 2.1 of the Program(presence of a Prohibited Substance in a Player’s Sample). She promptly admitted that she had committed the Anti-Doping Rule Violation charged, and asked for a hearing before an Independent Tribunal in accordance with Article 8 of the Program to determine the consequences to be imposed on her for that violation.
At a hearing on 19 July 2017, the Independent Tribunal received evidence and heard legal arguments from both parties, and subsequently issued a reasoned decision on 3 August, which is available at www.itftennis.com/antidoping. The Independent Tribunal determined that (1) Ms. Errani should serve a period of ineligibility of two months, beginning on 3 August and so ending at midnight on 2 October 2017; and (2) her results between 16 February 2017 (the date of sample collection) and 7 June 2017 (and the date of her next test, which was negative) should be disqualified, with resulting forfeiture of the ranking points and prize money that she won at events during that period.
The Tennis Anti-Doping Program applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed under the Program in compliance with the requirements of the World Anti-Doping Code. More information on the Program sanctions, statistics, and related matters can be found at www.itftennis.com/antidoping.
For more information, please contact:
Communications Department
International Tennis Federation
Tel: +44 (0)20 8392 4632
Email: communications@itftennis.com
25 Years at #1: Your best source of news about the Olympics iswww.aroundtherings.com, for subscribers only
Últimas Noticias
Sinner-Alcaraz, the duel that came to succeed the three phenomenons
Table tennis: Brazil’s Bruna Costa Alexandre will be Olympic and Paralympic in Paris 2024
Rugby 7s: the best player of 2023 would only play the medal match in Paris
Rhonex Kipruto, owner of the world record for the 10000 meters on the road, was suspended for six years
Katie Ledecky spoke about doping Chinese swimmers: “It’s difficult to go to Paris knowing that we’re going to compete with some of these athletes”
